查詢結果分析
相關文獻
- Staphylococcus Aureus Bacteremia and Endocarditis
- Clinical Features and Outcome of Infective Endocarditis in Maintenance Hemodialysis Patients
- Staphylococcus Aureus Endocarditis in an Uremic Patient Undergoing Continuous Ambulatory Peritoneal Dialysis
- 血液透析患者之感染性心內膜炎
- 鼻腔與金黃色葡萄球菌菌血症
- Vancomycin和其他glycopeptides抗藥性金黃色葡萄球菌之危機
- Methicillin抗藥性金黃色葡萄球菌菌血症的臨床表現與微生物學特徵:48個個案分析
- 以急性肺水腫表現之感染性心內膜炎
- 草綠色鏈球菌菌血症之臨床意義
- 發生在社區之Methicillin抗藥性金黃色葡萄球菌菌血症之流行病學分析
頁籤選單縮合
題名 | Staphylococcus Aureus Bacteremia and Endocarditis=金黃色葡萄球菌菌血症及心內膜炎 |
---|---|
作者 | 張峰義; | 書刊名 | 微免與感染雜誌 |
卷期 | 33:2 2000.06[民89.06] |
頁次 | 頁63-68 |
分類號 | 415.31 |
關鍵詞 | 金黃色葡萄球菌; 菌血症; 心內膜炎; Staphylococcus aureus bacteremia; Endocarditis; Methicillin-resistant staphylococcus aureus; MRSA; Methicillin-susceptible staphylococcus aureus; MSSA; |
語文 | 英文(English) |
英文摘要 | Staphylococcus aureus bacteremia is a serious and common disease often associated with infective endocarditis. It occurs in both healthy, immunologically competent people in the community and compromised patients in the hospitals. For S. aureus bacteremia, questions on clinical issues such as antimicrobial treatment are raised. Is nafcillin/oxacillin superior to vancomycin? Does the addition of rifampin improve outcome? Does addition of aminoglycoside improve the outcome? Does increasing duration of therapy (> 4 weeks versus < 2 weeks) improve outcome? How many cases of community-acquired S. aureus bacteremia have endocarditis on admission? What are the risk factors that would separate bacteremia from endocarditis? What is the role of echocardiography? What are the indications for routine echocardiography? Are methicillin-resistant S. aureus (MRSA) more virulent than methicillin-susceptible S. aureus (MSSA)? What factors predict mortality in S. aureus bacteremia? Herein, the above important issues on S. aureus bacteremia and endocarditis are critically reviewed. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。